SHIRLEY RYAN ABILITYLAB
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.3M
- Transactions
- 141
- Companies
- 18
- Average per transaction
- $23,607
Who reported the payments
| Ottobock SE & Co. Kgaa | $2,016,000 |
| Otto Bock Healthcare Products GmbH | $568,500 |
| AbbVie | $195,617 |
| Merz Pharmaceuticals, LLC | $192,500 |
| Baxter Healthcare | $110,000 |
| Merz North America, Inc. | $75,000 |
| Hollister Incorporated | $59,587 |
| Ipsen Pharma SAS | $40,784 |
| Tanabe Pharma America, Inc. | $29,932 |
| Hill-rom Holdings, Inc | $15,000 |
| Ipsen Biopharmaceuticals, Inc | $7,732 |
| Abbott | $7,333 |
| Saol Therapeutics Inc. | $5,030 |
| Eyetech Digital Systems, Inc. | $3,000 |
| Fisher Scientific Company L.L.C. | $1,651 |
| Stryker | $466 |
| Hikma Pharmaceuticals USA | $310 |
| Masimo Corporation | $86 |